PDS Biotechnology Corporation Banner Image

PDS Biotechnology Corporation

  • Ticker PDSB
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
PDS Biotechnology Corporation Logo Image
  • 11-50 Employees
  • Based in Princeton, New Jersey
PDS Biotech is a clinical-stage immunotherapy company with a growing pipeline of cancer immunotherapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology platform. Versamune® effectively delivers disease-specific antigens for in vivo uptake and processing, while also activating the critical type 1 interferon immunological pathwayMore, resulting in production of potent disease-specific killer T-cells as well as neutralizing antibodies. PDS Biotech has engineered multiple therapies, based on combinations of Versamune® and disease-specific antigens, designed to train the immune system to better recognize disease cells and effectively attack and destroy them.
4.8 / 5.0 (107)

PDS Biotechnology Corporation reports have an aggregate usefulness score of 4.8 based on 107 reviews.

PDS Biotechnology Corporation

Most Recent Annual Report

PDS Biotechnology Corporation
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

PDS Biotechnology Corporation Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!